Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma.

Hsiao LT, Yang CF, Yang SH, Gau JP, Yu YB, Hong YC, Liu CY, Liu JH, Chen PM, Chiou TJ, Tzeng CH.

Eur J Haematol. 2012 Feb;88(2):159-66. doi: 10.1111/j.1600-0609.2011.01717.x. Epub 2011 Nov 17.

PMID:
21973045
2.

The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?

Terpos E, Christoulas D, Kastritis E, Katodritou E, Pouli A, Michalis E, Papassotiriou I, Dimopoulos MA; Greek Myeloma Study Group.

Eur J Haematol. 2013 Oct;91(4):347-55. doi: 10.1111/ejh.12164. Epub 2013 Aug 17.

PMID:
23829647
3.

[Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].

Conté L G, Figueroa M G, Lois V V, Cabrera C ME, León R A, García L H, Rojas R H.

Rev Med Chil. 2008 Jan;136(1):7-12. doi: /S0034-98872008000100001. Epub 2008 Apr 30. Spanish.

4.

Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients.

Kleber M, Ihorst G, Deschler B, Jakob C, Liebisch P, Koch B, Sezer O, Engelhardt M.

Eur J Haematol. 2009 Dec 1;83(6):519-27. doi: 10.1111/j.1600-0609.2009.01318.x. Epub 2009 Jul 14.

PMID:
19614956
5.

International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents.

Yang SH, Teng HW, Hong YC, Liu CY, Yu YB, Yang CF, Gau JP, Liu JH, Chang TJ, Yen JJ, Chen PM, Chiou TJ, Tzeng CH, Hsiao LT.

Ann Hematol. 2012 Jan;91(1):93-102. doi: 10.1007/s00277-011-1251-y. Epub 2011 May 17.

PMID:
21584671
6.

[Clinical features and survival of Chilean patients with multiple myeloma].

Conté L G, Figueroa M G, Lois V V, Cabrera C ME, León R A, García L H, Rojas R H.

Rev Med Chil. 2007 Sep;135(9):1111-7. Epub 2007 Nov 15. Spanish.

7.

[Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].

Deng SH, Xu Y, Mai YJ, Wang YF, Zhao YZ, Zou DH, Qiu LG.

Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):217-21. Chinese.

PMID:
18843972
8.

MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function.

Lenihan CR, O'Kelly P, Mohan P, Little D, Walshe JJ, Kieran NE, Conlon PJ.

Ren Fail. 2008;30(4):345-52. doi: 10.1080/08860220801947686.

PMID:
18569905
9.

Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.

Perosa F, Minoia C, Favoino E, Prete M, Dammacco F.

Blood Cells Mol Dis. 2009 Jan-Feb;42(1):71-6. doi: 10.1016/j.bcmd.2008.09.003. Epub 2008 Nov 7.

PMID:
18996035
10.

International staging system for multiple myeloma.

Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J.

J Clin Oncol. 2005 May 20;23(15):3412-20. Epub 2005 Apr 4. Erratum in: J Clin Oncol. 2005 Sep 1;23(25):6281. Harousseau, Jean-Luc [corrected to Avet-Loiseau, Herve].

11.

Are eGFR equations better than IDMS-traceable serum creatinine in classifying chronic kidney disease?

Pottel H, Martens F.

Scand J Clin Lab Invest. 2009;69(5):550-61. doi: 10.1080/00365510902811253.

PMID:
19337946
12.

The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease.

Quinn MP, Rainey A, Cairns KJ, Marshall AH, Savage G, Kee F, Peter Maxwell A, Reaney E, Fogarty DG.

Nephrol Dial Transplant. 2008 Feb;23(2):542-8. Epub 2007 Sep 22.

PMID:
17890743
13.

[Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].

Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J.

Ai Zheng. 2006 Apr;25(4):461-4. Chinese.

PMID:
16613681
15.

Multiple myeloma in elderly patients: prognostic factors and outcome.

Anagnostopoulos A, Gika D, Symeonidis A, Zervas K, Pouli A, Repoussis P, Grigoraki V, Anagnostopoulos N, Economopoulos T, Maniatis A, Dimopoulos MA.

Eur J Haematol. 2005 Nov;75(5):370-5.

PMID:
16191085
16.

The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia.

Dimopoulos M, Gika D, Zervas K, Kyrtsonis M, Symeonidis A, Anagnostopoulos A, Bourantas K, Matsouka C, Pangalis G.

Leuk Lymphoma. 2004 Sep;45(9):1809-13.

PMID:
15223640
17.

The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations.

Praditpornsilpa K, Townamchai N, Chaiwatanarat T, Tiranathanagul K, Katawatin P, Susantitaphong P, Trakarnvanich T, Kanjanabuch T, Avihingsanon Y, Tungsanga K, Eiam-Ong S.

Nephrol Dial Transplant. 2011 Sep;26(9):2780-5. doi: 10.1093/ndt/gfq815. Epub 2011 Feb 28.

PMID:
21357214
18.

Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.

Li HX, Xu GB, Wang XJ, Zhang XC, Yang JM.

Chin Med J (Engl). 2010 Mar 20;123(6):745-51.

PMID:
20368098
19.

Prevalence and staging of chronic kidney disease in renal transplant recipients.

Costa de Oliveira CM, Mota MU, Mota RS, Nóbrega JO, Melo DS, Vieira AS, Fernandes PF, Campos Hde H, Evangelista JB Jr.

Clin Transplant. 2009 Sep-Oct;23(5):628-36. doi: 10.1111/j.1399-0012.2009.01023.x. Epub 2009 Jun 26.

PMID:
19563484
20.

Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.

Wong CF, McCarthy M, Howse ML, Williams PS.

Ren Fail. 2007;29(6):653-9. Erratum in: Ren Fail. 2008;30(3):343.

PMID:
17763158

Supplemental Content

Support Center